Pregnancy in type 2 diabetes mellitus - Problems & promises

Current Diabetes Reviews

Volumn 5, Issue 3, 2009, Pages 190-200

  McIntyre, H D ^a   Thomae, M K ^b   Wong, S F ^b   Idris, N ^c   Callaway, L K ^b  

^a Queensland Research Centre for Peripheral Vascular Disease   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Maternal Fetal Medicine Centre   (Australia)

Author keywords

Fetal outcomes; Hypertension; Maternal outcomes; Obesity; Pregnancy; Type 2 diabetes mellitus

Indexed keywords

ADIPONECTIN; AMYLIN; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INTERLEUKIN 6; LEPTIN; ORAL ANTIDIABETIC AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; RETINOL BINDING PROTEIN 4; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN;

BIRTH DEFECT; CONGENITAL HEART DISEASE; CONGENITAL MALFORMATION; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; INTRAUTERINE GROWTH RETARDATION; ISCHEMIC HEART DISEASE; LIMB DEFECT; MACROSOMIA; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; METABOLIC DISORDER; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEOPLASM; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PERINATAL MORTALITY; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TERATOGENICITY; UTERUS; VITAMIN DEFICIENCY; FEMALE; PREGNANCY COMPLICATION; PREGNANCY OUTCOME;

DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; RISK FACTORS;

EID: 70349787493     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339909788920893     Document Type: Review

References (122)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053
2. Yu CH, Zinman B. Type 2 diabetes and impaired glucose tolerance in aboriginal populations: a global perspective. Diabet Res Clin Pract 2007; 78(2): 159-170 (Pubitemid 47469993)
3. Shai I, Jiang R, Manson JE, et al. Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care 2006; 29(7): 1585-1590 (Pubitemid 44127585)
4. Dunstan DW, Zimmet PZ, Welborn TA, et al. On Behalf of the Australian Diabetes Steering Committee. The Rising Prevalence of Diabetes and Impaired Glucose Tolerance: The Australian diabetes, obesity and lifestyle study. Diabetes Care 2002; 25(5): 829-834
5. Callaway LK, Prins JB, Chang AM, McIntyre HD. The prevalence and impact of overweight and obesity in an Australian obstetric population. Med J Aust 2006; 184(2): 56-59 (Pubitemid 43174192)
6. Barnett AH, Eff C, Leslie RD, Pyke DA. Diabetes in identical twins. A study of 200 pairs. Diabetologia 1981; 20: 87-93.
7. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445: 881-885 (Pubitemid 46309843)
8. Zeggini E, Scott LJ, Saxena R, et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008; 40(5): 638-645 (Pubitemid 351601209)
9. Sandhu MS, Weedon MN, Fawcett KA, et al. Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet 2007; 39: 951-953
10. Cook JT, Hattersley AT, Christopher P, et al. Linkage analysis of glucokinase gene with NIDDM in Caucasian pedigrees. Diabetes 1992; 41(11): 1496-1500
11. Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 1997; 17: 138-139
12. Macfarlane WM, Frayling TM, Ellard S, et al. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J Clin Invest 1999; 104(9): R33-R39. (Pubitemid 29536302)
13. Kadowaki T, Kadowaki H, Mori Y, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994; 330: 962-968 (Pubitemid 24103594)
14. Ji L, Malecki M, Warram JH, Yang Y, Rich SS, Krolewski AS. New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes 1997; 46: 876-881 (Pubitemid 27188267)
15. Mahtani MM, Widen E, Lehto M, et al. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet 1996; 14: 90-94 (Pubitemid 26301553)
16. Rothman DL, Magnusson I, Cline G, et al. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1995; 92(4): 983-987
17. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004; 350: 664-671 (Pubitemid 38364625)
18. Kahn CR. Banting Lecture: Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994; 43(8): 1066-1084 (Pubitemid 24230714)
19. Thorens B. A toggle for type 2 diabetes? N Engl J Med 2006; 354(15): 1636-1638
20. Brunham LR, Kruit JK, Pape TD, et al. Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med 2007; 13: 340-347
21. Groop LC, Kankuri M, Schalin-Jantti C, et al. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med 1993; 328: 10-14 (Pubitemid 23011465)
22. Cline GW, Petersen KF, Krssak M, et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 1999; 341: 240-246 (Pubitemid 29334522)
23. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the β3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995; 333: 348-352
24. Deeb SS, Fajas L, Nemoto M, et al. A Prol12Ala substitution in PPAR gamma 2 is associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 284-287 (Pubitemid 28507675)
25. Withers DJ, Gutierrez JS, Towery H, et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998; 391: 900-904 (Pubitemid 28157668)
26. Hanis CL, Boerwinkle E, Chakraborty R, et al. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 1996; 13: 161-166 (Pubitemid 26000435)
27. Boden G, Chen X. Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest 1995; 96(3): 1261-1268
28. Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003; 52(7): 1799-1805
29. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286(3): 327-334 (Pubitemid 32656163)
30. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002; 51(2): 455-461 (Pubitemid 34764803)
31. Morioka T, Asilmaz E, Hu J, Dishinger JF. Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J Clin Invest 2007; 117(10): 2860-2868 (Pubitemid 47529616)
32. Niswender KD, Magnuson MA. Obesity and the beta cell: lessons from leptin. J Clin Invest 2007; 117(10): 2753-2756
33. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116(7): 1784-1792 (Pubitemid 44033298)
34. de Rekeneire N, Peila R, Ding J, et al. Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study. Diabetes Care 2006; 29(8): 1902-1908 (Pubitemid 44156650)
35. Kanaya AM, Wassel Fyr C, Vittinghoff E, et al. Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1. Arch Intern Med 2006; 166(3): 350-356 (Pubitemid 43244324)
36. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259(5091): 87-91. (Pubitemid 23036092)
37. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997; 389(6651): 610-614
38. Graham TE, Yang Q, Bluher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006; 354(24): 2552-2563 (Pubitemid 43882351)
39. Gavi S, Stuart LM, Kelly P, et al. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes. J Clin Endocrinol Metab 2007; 92(5): 1886-1890 (Pubitemid 46997205)
40. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409(6818): 307-312 (Pubitemid 32151228)
41. Bennet WM, Beis CS, Ghatei MA, Byfield PG, Bloom SR. Amylin totally regulates arginine-stimulated insulin secretion in rats. Diabetologia 1994; 37(4): 436-438 (Pubitemid 24113578)
42. Burke JP, Forsgren J, Palumbo PJ, et al. Association of birth weight and type 2 diabetes in Rochester, Minnesota. Diabetes Care 2004; 27(10): 2512-2513 (Pubitemid 39281415)
43. Hofman PL, Regan F, Jackson WE, et al. Premature birth and later insulin resistance. N Engl J Med 2004; 351(21): 2179-2186 (Pubitemid 39507630)
44. Dyck RF, Klomp H, Tan L. From "thrifty genotype" to "hefty fetal phenotype": the relationship between high birthweight and diabetes in Saskatchewan Registered Indians. Can J Public Health 2001; 92(5): 340-344 (Pubitemid 33107626)
45. Prins JB. Adipose tissue as an endocrine organ. Best Pract Res Clin Endocrinol Metab 2002; 16(4): 639-651
46. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444(7121): 860-867
47. Haslam DW, James WP. Obesity. Lancet 2005; 366(9492): 1197-1209
48. O'Rahilly S, Farooqi IS. Genetics of obesity. Philos Trans R Soc Lond 2006; 361(1471): 1095-1105
49. Bouchard C, Tremblay A, Despres JP, et al. Overfeeding in identical twins: 5-year postoverfeeding results. Metabolism 1996; 45(8): 1042-1050 (Pubitemid 26282561)
50. Coll AP, Farooqi IS, O'Rahilly S. The hormonal control of food intake. Cell 2007; 129(2): 251-262
51. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444(7121): 840-846 (Pubitemid 46024990)
52. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365(9468): 1415-1428
53. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444(7121): 875-880 (Pubitemid 46028447)
54. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol 2006; 26(5): 968-976 (Pubitemid 43732100)
55. Pagemann A. Perinatal programming and functional teratogenesis: impact on body weight regulation and obesity. Physiol Behav 2005; 86(5): 661-666
56. Gunton JE, McElduff A, Sulway M, et al. Outcome of pregnancies complicated by pre-gestational diabetes mellitus. Aust NZ J Obstet Gynaecol 2000; 40(1): 38-43. (Pubitemid 30153937)
57. Gunton JE, Morris J, Boyce S, Kelso I, McElduff A. Outcome of pregnancy complicated by pregestational diabetes - improvement in outcomes. Aust N Z J Obstet Gynaecol 2002; 42(5): 478-481 (Pubitemid 35385682)
58. McElduff A, Ross GP, Lagström JA, et al. Pregestational diabetes and pregnancy: an Australian experience. Diabetes Care 2005; 28: 1260-1261 (Pubitemid 40616653)
59. Hillman N, Herranz L, Vaquero PM, Villarroel A, Fernandez A, Pallardo LF. Is pregnancy outcome worse in type 2 than in type 1 diabetic women? Diabetes Care 2006; 29: 2557-2558
60. Cheung NW, McElduff A, Ross GP. Type 2 diabetes in pregnancy: a wolf in sheep's clothing. Aust N Z J Obstet Gynaecol 2005; 45: 479-483 (Pubitemid 43904708)
61. Moore TR, Warshak C. Diabetes Mellitus and Pregnancy: eMedicine from WebMD [Internet] 2005 Jan [updated 2007 Dec 7, cited 2007 Nov 23]. Available from: http://www.emedicine.com/med/topic3249.html
62. Clausen TD, Mathiesen M, Ekbom P, Hellmuth E, Mandrup-Poulsen T, Damm P. Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care 2005; 28(2): 323-328 (Pubitemid 40170934)
63. Diabetes and Pregnancy Group, France. French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 2003; 26(11): 2990-2993
64. Rossing K, Jacobsen P, Hommel E, et al. Pregnancy and progression of diabetic nephropathy. Diabetologia 2002; 45: 36-41.
65. Landon MB. Diabetic nephropathy and pregnancy. Clin Obstet Gynecol 2007; 50(4): 998-1006.
66. Purdy LP, Hantsch CE, Molitch ME, et al. Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency. Diabetes Care 1996; 19(10): 1067.
67. Ekbom P, Damm P, Feldt-Rasmussen B, Feldt-Rasmussen U, Mølvig J, Mathiesen ER. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 2001; 24: 1739-1744 (Pubitemid 33716475)
68. Fayomi O, Nazardoi R. Acute myocardial infarction in pregnancy: a case report and subject review. Emerg Med J 2007; 24; 800-801 (Pubitemid 350055193)
69. CEMACH. Why Mothers Die 2000-2002: Report on confidential enquiries into maternal deaths in the United Kingdom. London: Royal College of Obstetrics and Gynaecology Press, 2004.
70. Bagg W, Henley PG, Macpherson P, Cundy TF. Pregnancy in women with diabetes and ischaemic heart disease. Aust N Z J Obstet Gynaecol 1999; 39: 99-102. (Pubitemid 29108195)
71. Solomon CG, Seely EW. Hypertension in pregnancy. Endocrinol Metab Clin North Am 2006; 35(1): 157-171
72. Sibai BM, Dekker G, Kupferminic M. Preeclampsia. Lancet 2005; 365(9461): 785-799
73. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006; 195(1): 40-49 (Pubitemid 43927490)
74. Hiby SE, Walker JJ, O'Shaughnessy KM, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200(8): 957-965
75. Wimalasundera RC, Larbalestier N, Smith JH, et al. Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet 2002; 360(9340): 1152-1154 (Pubitemid 35246493)
76. Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998; 16: 5-15.
77. Cohen A, Lim K-H, Lee Y, et al. Angiogenic markers in preeclampsia and preexisting diabetes circulating levels of the antiangiogenic marker soluble FMS-like tyrosine kinase 1 are elevated in women with pregestational diabetes and preeclampsia. Diabetes Care 2007; 30(2): 375-377 (Pubitemid 46198350)
78. Irani RA, Xia Y. The functional role of the renin-angiotensin system in pregnancy and preeclampsia. Placenta 2008; 29: 763-771
79. Wallukat G, Homuth V, Fischer T, et al. Patients with preeclampsia develops agonistic autoantibodies against theangiotensin AT1 receptor. J Clin Invest 1999; 103: 945-952 (Pubitemid 29169601)
80. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005; 330(7491): 565.
81. Arngrimsson R, Bjornsson S, Geirsson RT, Bjornsson H, Walker JJ, Snaedal G. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol 1990; 97(9): 762-769 (Pubitemid 20283312)
82. Esplin MS, Fausett MB, Fraser A, et al. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 2001; 344(12): 867-872 (Pubitemid 32224394)
83. Disentangling fetal and maternal susceptibility for pre-eclampsia: a British multicenter candidate-gene study. Am J Hum Genet 2005; 77(1): 127-131
84. Cundy T, Slee F, Gamble G, Neale L. Hypertensive disorders of pregnancy in women with Type 1 and Type 2 diabetes. Diabet Med 2002; 19: 482-489 (Pubitemid 34639159)
85. Lapolla A, Dalfra MG, Lencioni C, Di Cianni G. Epidemiology of diabetes in pregnancy: A review of Italian data. Diabetes Nutr Metab 2004; 17: 358-367
86. Hughes R, Rowan J. Perinatal outcomes and macrosomia in a multi-ethnic population of women with type 2 diabetes. Aust N Z J Obstet Gynaecol 2006; 46: 552-555 (Pubitemid 44762481)
87. Garner PR, D'Alton ME, Dudley DK, Huard P, Hardie M. Preeclampsia in diabetic pregnancies. Am J Obstet Gynecol 1990; 163(2): 505-508
88. Sibai BM, Caritis S, Hauth J, et al. Risks of preeclampsia and adverse neonatal outcomes among women with pre-gestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000; 182(2): 364-369
89. Vääräsmäki MS, Hartikainen A-L, Anttila M, Pramila S, Koivisto M. Factors predicting peri- and neonatal outcome in diabetic pregnancy. Early Hum Dev 2000; 59: 61-70. (Pubitemid 30658013)
90. Greene MF, Hare JW, Cloherty JP, Benacerraf BR, Soeldner JS. First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy.Teratology 1989; 39: 225-231
91. Kovilam O, Khoury J, Miodovnik M, Chames M, Spinnoto J, Sibai B. Spontaneous preterm delivery in the type I diabetic pregnancy: the role of glycemic control. J Matern Fetal Neonat Med 2002; 11(4): 245-248 (Pubitemid 34836914)
92. The diabetes control & complications trial research group. Effect of pregnancy on microvascular complications in the diabetes control & complications trial. Diabetes Care 2000; 23(8): 1084-1091
93. Cundy T, Gamble G, Townend K, Henley PG, MacPherson P, Roberts AB. Perinatal mortality in Type 2 diabetes mellitus. Diabet Med 2000; 17: 33-39 (Pubitemid 30094178)
94. Roland JM, Murphy HR, Ball V, Northcote-Wright J, Temple RC. The pregnancies of women with Type 2 diabetes: poor outcomes but opportunities for improvement. Diabet Med 2005; 22: 1774-1777 (Pubitemid 43046485)
95. Chaudhry T, Ghani AM, Mehrali TH, et al. A comparison of foetal and labour outcomes in Caucasian and Afro-Caribbean women with diabetes in pregnancy. Int J Clin Pract 2004; 58(10): 932-936 (Pubitemid 39642615)
96. Huddle K. Audit of the outcome of pregnancy in diabetic women in Soweto, South Africa, 1992-2002. S Afr Med J 2005; 95(10): 789-794
97. Verheijen EC, Critchley JA, Whitelaw DC, Tuffnell DJ. Outcomes of pregnancies in women with pre-existing type 1 or type 2 diabetes, in an ethnically mixed population. BJOG 2005; 112: 1500-1503 (Pubitemid 43961236)
98. Forsbach-Sanchez G, Tamez-Perez HE, Vazquez-Lara J. Review article: Diabetes and pregnancy. Arch Med Res 2005; 36: 291-299
99. Vangen S, Stoltenberg C, Holan S, et al. Outcome of pregnancy among immigrant women with diabetes. Diabetes Care 2003; 26: 327-332 (Pubitemid 36929050)
100. dos Santos SI, Higgins C, Swerdlow AJ, et al. Birthweight and other pregnancy outcomes in a cohort of women with pregestational insulin-treated diabetes mellitus, Scotland, 1979-1995. Diabet Med 2005; 22: 440-447
101. Vääräsmäki M, Gissler M, Ritvanen A, Hartikainen A-L. Congenital anomalies and first life year surveillance in Type 1 diabetic births. Diabet Med 2002; 19: 589-593 (Pubitemid 35300681)
102. Chan BW, Chan K, Koide T, et al. Maternal diabetes increases the risk of caudal regression caused by retinoic acid. Diabetes 2002; 51: 2811-2816 (Pubitemid 34970935)
103. Farrell T, Neale L, Cundy T. Congenital anomalies in the offspring of women with Type 1, Type 2 and gestational diabetes. Diabet Med 2002; 19: 322-326
104. Hadden DR. How to improve prognosis in Type 1 diabetic pregnancy: Old problems, new concepts. Diabetes Care 1999; 22(S2): B104-8.
105. Confidential Enquiry into Maternal and Child Health: Pregnancy in women with type 1 and type 2 diabetes in 2002-2003, England, Wales and Northern Ireland. London: CEMACH 2005.
106. CATI Technical Reference Group, National Public Health Partnership. Diabetes in Australia. Population Health Monitoring and Surveillance: Question Development Background Paper May 2003.
107. Moore LL, Singer MR, Bradlee ML, Rothman KJ, Milunsky A. A prospective study of the risk of congenital defects associated with maternal obesity and diabetes mellitus. Epidemiology 2000; 11(6): 689-694 (Pubitemid 30796729)
108. Hughes R, Rowan J. Perinatal outcomes and macrosomia in a multi-ethnic of women with type 2 diabetes. Aust NZ J Obstet Gynecol 2006; 46: 552-555 (Pubitemid 44762481)
109. McElvy SS, Miodovnik M, Rosenn B, et al. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern Fetal Med 2000; 9(1): 14-20. (Pubitemid 30176207)
110. Kinsley B. Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus. Clin Ther 2007; 29(Suppl D): S153-S160.
111. Murphy HR, Temple RC, Roland JM. Improving outcomes of pregnancy for women with type 1 and type 2 diabetes. Br J Diabet Vasc Dis 2007; 7(1): 38-42. (Pubitemid 46431648)
112. Kalhan SC, Savin SM, Adam PA. Attenuated glucose production rate in newborn infants of insulin-dependent diabetic mothers. N Engl J Med 1977; 296: 375-376
113. Taylor R, Lee C, Kyne-Grzebalski D, Marshall SM, Davison JM. Clinical outcomes of pregnancy in women with type 1 diabetes. Obset Gynecol 2002; 99(4): 537-541 (Pubitemid 34246284)
114. Cordero L, Treuer SH, Landon MB, Gabbe SG. Management of infants of diabetic mothers. Arch Pediatr Adolesc Med 1998; 152(3): 249-254
115. Yajnik CS. Early life origins of insulin resistance and type 2 diabetes in india and other asian countries. J Nutr 2004; 134: 205-210
116. Ray JG, O'Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. Q J Med 2001; 94: 435-444
117. McElduff A, Cheung NW, McIntyre HD, et al. The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy. Med J Aust 2005; 183(7): 373-377 (Pubitemid 41430840)
118. McIntyre HD, Flack JR. Consensus statement on diabetes control in preparation for pregnancy. Med J Aust 2004; 181: 326. (Pubitemid 39302718)
119. Wentzel P, Gäreskog M, Eriksson UJ. Folic acid supplementation disminishes diabetes- and glucose-induced dysmorphogenesis in rat embryos in vivo and in vitro. Diabetes 2005; 54: 546-547
120. ACOG committee on practice bulletins: ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 2003; 44: 203-213
121. Wilson RD, Davies G, Desilets V, et al. Genetics Committee and Executive and Council of the Society of Obstetricians and Gynaecologists of Canada: The use of folic acid for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol 2003; 25: 959-973
122. Capel I, Corcoy R. What dose of folic acid should be used for pregnant diabetic women? Letter In: Diabetes Care 2007; 30: e63.